Trends of vasopressor using in medical intensive care unit: a 7-year cohort study

dc.contributor.author

Srivali, Narat

dc.contributor.author

Thongprayoon, Charat

dc.contributor.author

Cheungpasitporn, Wisit

dc.contributor.author

Kashani, K

dc.date.accessioned

2023-11-24T00:06:45Z

dc.date.available

2023-11-24T00:06:45Z

dc.date.issued

2015-10-01

dc.date.updated

2023-11-24T00:06:42Z

dc.description.abstract

Introduction The use of vasopressor was common in medical intensive care unit (MICU). Due to the lack of conclusive evidence in superiority in efficacy among various types of vasopressors, the choice of vasopressor use mainly depends on the physician preference.

Objectives This study aims to describe the prevalence of vasopressor use and the trend in the use of each vasopressor medication in MICU over the past 7 years.

Methods This is a descriptive study conducted at a tertiary referral hospital. All MICU admissions at our institution between January 2007 and December 2013 were included in this study. The use of vasopressor within given ICU day (12.00 am - 11.59 pm) during ICU stay was reviewed. Vasopressors were defined as the continuous intravenous administration of norepinephrine, epinephrine, dopamine, phenylephrine, or vasopressin regardless of duration and dosage. The use of each vasopressor was reported as the vasopressor utilization index (VUI), using the following formula Vasopressor utilization index (VUI) = The total number of ICU days on a given vasopressor/The total number of ICU days on any vasopressor.

Results A total of 16,863 unique patients had 17,164 MICU admissions in the course of study, (55,391patient*ICU day).Out of 7,739 ICU days with vasopressor use, norepinephrine was used for 6,414 (83%), vasopressin for 1,960 (25%), phenylephrine for 772 (10%), dopamine for 623 (8%), and epinephrine for 323 (4%). From 2007 through 2013, there was an increasing trend in the use of norepinephrine (VUInorepinephrine was 0.69 in 2007 and 0.91 in 2013) and an slight increasing trend in the use of epinephrine (VUIepinephrine was 0.01 in 2007 and 0.06 in 2013). There was a decreasing trend in the use of dopamine (VUIdopamine was 0.15 in 2007 and 0.03 in 2013), vasopressin (VUIvasopressin was 0.42 in 2007 and 0.22 in 2013), and a slight downward trend in the use of phenylephrine.

Conclusions Norepinephrine is the most commonly used vasopressor in MICU. The use of norepinephrine and epinephrine are in upward trajectory.

dc.identifier.issn

2197-425X

dc.identifier.issn

2197-425X

dc.identifier.uri

https://hdl.handle.net/10161/29406

dc.publisher

SpringerOpen

dc.relation.ispartof

Intensive Care Medicine Experimental

dc.relation.isversionof

10.1186/2197-425X-3-S1-A960

dc.title

Trends of vasopressor using in medical intensive care unit: a 7-year cohort study

dc.type

Conference

duke.contributor.orcid

Srivali, Narat|0000-0002-6945-329X

pubs.begin-page

1

pubs.end-page

2

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Medicine

pubs.organisational-group

Medicine, Pulmonary, Allergy, and Critical Care Medicine

pubs.publication-status

Published

pubs.volume

3

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2197-425X-3-S1-A960.pdf
Size:
265.22 KB
Format:
Adobe Portable Document Format
Description:
Published version